Skip to main content

Alvaro Garcia Tornel Garcia Camba

Institutions of which they are part

Senior researcher
Stroke research
Vall Hebron Institut de Recerca

Alvaro Garcia Tornel Garcia Camba

Institutions of which they are part

Senior researcher
Stroke research
Vall Hebron Institut de Recerca

Projects

Development and validation of an artificial intelligence model for the prehospital management of patients with a suspected acute ischemic stroke

IP: Marc Ribó Jacobi
Collaborators: Alvaro Garcia Tornel Garcia Camba, Judit Álvarez González
Funding agency: Instituto de Salud Carlos III
Funding: 180000
Reference: JR22/00046
Duration: 01/01/2023 - 31/12/2026

HARMONICS. Harmonization and Implementation of High Value Stroke Care

IP: Carlos Molina Cateriano
Collaborators: Maria Baladas Orti, Ester Sanchez Gavilan, Cristina Guirao Martinez, Estefania Montiel, Marina Jimenez Iglesias, Lidia Garcia Guillamón, Judith Cendrero Correa, Federica Rizzo, Marta Aurora Rubiera Del Fueyo, David Rodriguez Luna, Manuel Requena Ruiz, Marta Olive Gadea, Alvaro Garcia Tornel Garcia Camba, Marc Rodrigo Gisbert
Funding agency: EUROPEAN COMMISSION
Funding: 468090
Reference: HARMONICS_EIT-HEALTH-BP2022
Duration: 01/01/2022 - 31/12/2024

NORA-HOME. EFICIENCIA Y SEGURIDAD DE UN MODELO DE MONITORIZACION MULTIMODAL AMBULATORIA EN PACIENTES CON ICTUS MINOR Y AITS.

IP: Mª Ángeles Muchada López
Collaborators: Carlos Molina Cateriano, Alvaro Garcia Tornel Garcia Camba, Marc Rodrigo Gisbert
Funding agency: Instituto de Salud Carlos III
Funding: 123420
Reference: PI22/01928
Duration: 01/01/2023 - 31/12/2025

Aplicación de la inteligencia artificial en el manejo del ictus agudo

IP: Marc Ribó Jacobi
Collaborators: Alvaro Garcia Tornel Garcia Camba
Funding agency: Instituto de Salud Carlos III
Funding: 53732
Reference: CM20/00025
Duration: 01/01/2021 - 31/12/2022

Related news

The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.

Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.

The award is a recognition for his significant contribution to the development of research in multiple sclerosis within the Catalan Institute of Health.

Related professionals

Lis Vidal Valdivia

Lis Vidal Valdivia

Donation and transplantation of organs, tissues and cells
Read more
Tetiana Gonchorova Simón

Tetiana Gonchorova Simón

Read more
Erica Espejo Basilio

Erica Espejo Basilio

Medium Grade Technician
IT / Information Systems
Digital Transformation Directorate
Read more
Elga Schreiber Bru

Elga Schreiber Bru

Tècnic/a Grau Superior
International Unit
Competitive Research Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.